权益分类	功能权益	普通用户	{{item.name}}会员
{{category.name}}	{{benefitItem.name}}

Map Leukemia-immune Cell Talks with Nanoplasmon Ruler in CAR T-Cell Immunotherapy

在 CAR T 细胞免疫疗法中使用 Nanoplasmon Ruler 绘制白血病免疫细胞对话图

基本信息

批准号：
10159877
负责人：
Pengyu Chen
金额：
$ 52.36万
依托单位：
NEW YORK UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2020
资助国家：
美国
起止时间：
2020-07-01 至 2025-06-30
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10159877
关键词：
Address B-Cell Acute Lymphoblastic Leukemia B-Lymphocytes B-cell precursor acute lymphoblastic leukemia cell Behavior Biosensing Techniques Biosensor Bone Marrow CAR T cell therapy CD19 Antigens CD19 gene Cell Communication Cell physiology Cells Characteristics Clinical Communication Complex Cytokine Network Pathway Development Diffusion Engineering Enzymes Fingerprint Functional disorder Genetic Engineering Hybrids Immune Immune signaling Immunity Immunologics Immunosuppressive Agents Immunotherapy Impairment In Situ Individual Label Leukemic Cell Location Malignant Neoplasms Maps Measurement Methods Microfluidics Monitor Outcome Population Preventive treatment Procedures Production Refractory Relapse Research Resistance Signal Pathway Signal Transduction Suppressor-Effector T-Lymphocytes T cell response T-Cell Activation T-Lymphocyte Techniques Technology Therapeutic Time Transportation Tumor Antigens Tumor Immunity Tumor-infiltrating immune cells Visualization acute T-cell lymphoblastic leukemia cell aptamer base cancer cell cell type chimeric antigen receptor chimeric antigen receptor T cells clinical application clinical practice cytokine cytokine release syndrome cytotoxicity design engineered T cells exhaustion improved individual variation innovation insight leukemia nanoplasmonic nanosensors novel patient response practical application pre-clinical preclinical evaluation programs response screening sensor spatiotemporal success therapy outcome therapy resistant tool tumor microenvironment

项目摘要

Map Leukemia-immune Cell Communication with Nanoplasmon Ruler in CAR T-Cell Immunotherapy Genetically engineered T-cells modified with chimeric antigen receptors (CAR) targeting CD19 provide an innovative method for treating cancer, especially for B-cell acute lymphoblastic leukemia (B-ALL). Unfortunately, practical application of this immunotherapy is greatly hindered by the unsatisfactory CAR T-cell function, long- lasting B cell aplasia and accompanied cytokine release syndrome (CRS). Improved therapeutic and preventive treatments require comprehensive understanding of the complex and dynamic cytokine secretion behavior of CAR T-cells and their communication with cancer cells and other immune cells in the tumor microenvironment. More importantly, real-time and traceable monitoring of both the location and timing of cytokine secretion would enable mechanistic understanding of CAR T-cell physiopathology in initiation, activation, communication and subsequent functional responses in leukemic bone marrow immunity. Such spatiotemporal monitoring technique is critically lacking within existing clinical practices, which are primarily based on measurements under “static” conditions. Thus, there is an emerging need for platforms that allow direct visualization and mapping of cytokine production, diffusion, transportation for better understanding the highly heterogeneous functional diversity of polyfunctional CAR T-cells and immune cell communications. To address this need, the central objectives of this proposal are to develop novel integrated `nanoplamson ruler'-based nanosensing technology to resolve the temporal dynamics of cytokine secretion from individual CD19 CAR T-cells and the crosstalk with B-ALL cells and bone marrow immune suppressor cells. The success of this technology will allow, for the first time, the direct visualization of multiplex cytokine secretion from individual CAR T-cell in a high-sensitivity, multiplex, label-free, in situ and real-time traceable manner. The proposed platform would provide a detailed and time-dependent mechanisms of how CAR T-cell response to stimulation and evolve in a suppressive niche for preclinical screening of optimal, effective and safe CAR T-cell therapy.

利用纳米等离子体调控子在CAR - t细胞免疫治疗中定位白血病-免疫细胞通讯